Morning After Pill - Politics Slaps Science Down, And Wins

Even though America has, by far, the highest rates of unwanted and unplanned teenage pregnancies in the developed world, and the FDA wanted to make the Morning-After-Pill, otherwise known as Plan B One-Step, available as an over-the-counter (OTC) drug to all females of reproductive age, HHS Secretary Kathleen Sebelius slapped them down and said [...]

Researchers Find Smoking Is Strongly Associated With Squamous Cell Carcinoma Among Women

Women who have non-melanoma skin cancers are more likely to have smoked cigarettes compared to women without skin cancer, said researchers at Moffitt Cancer Center in Tampa, Fla., who published study results in a recent issue of Cancer Causes Control…

FDA to Rule on Potential BPA Food Packaging Ban

In a settlement reached this week, the FDA agreed to rule on the safety of BPA in consumer products by the end of March 2012. Medscape Medical News

Stroke Risk Reduced With Treatment of Prehypertension

A new meta-analysis shows that the patients who take any class of antihypertensive medication have a significantly lowered risk for stroke. Medscape Medical News

Childhood Obesity Interventions Focusing on Environment Pay Off

An international review of a broad range of strategies shows the greatest efficacy when healthy eating and physical activity are emphasized. Medscape Medical News

Top 10 in 2011: Most-Read Articles by Public Health Professionals

Which articles were most read by your colleagues during the past year? Medscape Public Health

IOM: Lifestyle Changes to Prevent Breast Cancer Needed

What should healthcare providers advise patients about lifestyle changes that may reduce breast cancer risks? Medscape Medical News

FDA Panel Gives Tepid Okay to Birth Control Pill

ADELPHI, Md. (MedPage Today) — In a lukewarm endorsement, an FDA advisory panel voted 15-11 that the benefits of controversial drospirenone-containing oral contraceptives such as Yaz and Yazmin outweigh the risk of venous thromboembolism.

New Study Adds to Negative Votes on Mammography (CME/CE)

(MedPage Today) — After 10 years of mammograms, a woman may get more harm than good from the screening, researchers from the U.K. found.

FDA Approves Gel for Overactive Bladder

WASHINGTON (MedPage Today) — The FDA has approved a topical gel formulation of oxybutynin 3% for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.